This inventor holds 2 USPTO granted patents. Top assignee: Zeneca Limited. Active years: 2001-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2003
Title: Innovations of Peter Wedderburn Kenny
Introduction
Peter Wedderburn Kenny is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of farnesyl transferase inhibitors. With a total of 2 patents, his work is recognized for its potential applications in cancer therapy.
Latest Patents
Kenny's latest patents include innovative pharmaceutical compositions comprising 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors. These compositions are designed to inhibit ras farnesylation, with specific formulas that include various substituents and linking moieties. The compounds are selected for their potential use in cancer therapy, showcasing Kenny's commitment to advancing medical science.
Career Highlights
Peter Wedderburn Kenny is associated with Zeneca Limited, where he has contributed to groundbreaking research and development in pharmaceuticals. His expertise in the field has led to the creation of valuable therapeutic agents that address critical health challenges.
Collaborations
Kenny has worked alongside esteemed colleagues such as David Huw Davies and Francis Thomas Boyle. Their collaborative efforts have further enhanced the impact of their research in the pharmaceutical industry.
Conclusion
Peter Wedderburn Kenny's innovative work in developing farnesyl transferase inhibitors highlights his significant role in advancing cancer therapy. His contributions continue to influence the pharmaceutical landscape, making a lasting impact on medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile